Justification of sample size for the generation of a prediction model


7

1494

January 11, 2023

Should we account for competing risk when estimating incidence rate?


3

678

January 5, 2023

Precisionbased sample size calculation for one survival curve


3

976

November 16, 2022

Conceptual question about survival analysis vs logistic regression: when is one more appropriate than the other?


16

13338

October 27, 2022

Background to PFS endpoint


19

6827

October 6, 2022

Method to obtain optimal cutoff point for survival outcomes


3

2208

October 1, 2022

Could cardiovescular risk nomogram be supirior than the Framingham Risk Score? If so, what could be the reasons?


0

694

September 20, 2022

Elastic net model for nonlinear relationship?


2

2818

July 26, 2022

Intervention with early survival benefit, questionable long term harm


8

2105

May 26, 2022

Schoenfeld Residuals


1

2265

May 23, 2022

Comparing nonnested models on the same data


4

3715

May 13, 2022

Should I impute persontime before conducting proportional hazards analysis?


7

1965

May 8, 2022

Stratification on a variable involved in an interaction term


3

1637

May 4, 2022

Validation of cox model


4

4733

May 2, 2022

Cutpoint for Estimation of Prognostic value of a continuous Marker


5

2303

May 2, 2022

How should I compare crossing survival curves?


5

4241

April 28, 2022

Is logistic regression or survival analysis most appropriate in this case?


1

1637

April 28, 2022

Statistical power estimation for a timedependent covariate in Cox (proportional hazards) regression


0

1447

April 19, 2022

Propensity score weighting and competing risks


2

2553

March 30, 2022

How to calculate number of events in each treatment arm given hazard ratio and CI?


2

2258

March 6, 2022

RMS Case Study in Cox Regression


1

15182

September 17, 2021

How to use RCS in mixed effects cox regression


3

4011

December 10, 2021

KaplanMeier: SE for absolute difference in timepoint survival


13

4114

October 30, 2021

How can I determined the best cutoff for survival ROC


1

2299

October 10, 2021

First RCT of Lopinavir–Ritonavir on SARSCoV2


38

17128

October 8, 2021

What is the best way to establish correlation between two timetoevent analysis?


6

3612

September 13, 2021

How to handle MNAR from a covariate due to witnessing the survival outcome?


2

1986

September 10, 2021

Cox regression vs. competing risk regression?


9

8094

August 23, 2021

Probability in state Ps(t) and Hazard ratio HR in Cox model


1

2179

August 21, 2021

Restricted mean survival time and comparing treatments under nonproportional hazards


6

5677

August 10, 2021
